ADULT ACUTE MYELOMONOCYTIC LEUKEMIA
Clinical trials for ADULT ACUTE MYELOMONOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ADULT ACUTE MYELOMONOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ADULT ACUTE MYELOMONOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to boost remission in tough leukemia cases
Disease control OngoingThis study tests whether adding a drug called decitabine to standard chemotherapy can improve remission rates in adults with acute myeloid leukemia (AML) that is harder to treat. About 178 participants will receive either low or high dose decitabine alongside chemo drugs daunorub…
Matched conditions: ADULT ACUTE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New combo therapy shows promise for older leukemia patients
Disease control OngoingThis study tested a combination of two drugs, azacitidine and gemtuzumab ozogamicin, in 133 adults aged 60 and older with untreated acute myeloid leukemia (AML). The goal was to see if the combination could safely lead to complete remission (no signs of cancer) and improve surviv…
Matched conditions: ADULT ACUTE MYELOMONOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC